Skip to main content
Erschienen in: Community Mental Health Journal 2/2013

01.04.2013 | Original Paper

A Case Control Study of the Implementation of Change Model Versus Passive Dissemination of Practice Guidelines for Compliance in Monitoring for Metabolic Syndrome

verfasst von: Dawn I. Velligan, Desiree Castillo, Linda Lopez, Bren Manaugh, Charlotte Davis, Juanita Rodriguez, A. Camis Milam, Albana Dassori, Alexander L. Miller

Erschienen in: Community Mental Health Journal | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

We developed an intervention to improve compliance with guidelines for monitoring metabolic syndrome and compared compliance prior to intervention and three times post-intervention at three community mental health clinics in Texas. One test clinic received intervention and two other clinics served as controls. Fifty random charts were reviewed from each clinic for three specific, 1–2 weeks periods over the course of 18 months. There were significant improvements in the ordering of labs, the presence of lab results in the chart, and documentation of blood pressure, body mass index and waist circumference in the intervention clinic over time in comparison to the control clinics. Documented evidence of physician action with respect to out of range values remained low. Metabolic monitoring is a multi-step process. Removing barriers, creating specific procedures, and dedicating staff resources can improve compliance with monitoring.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Cabana, M. D., Rand, C. S., Pow, N. R., Wu, A. W., Wilson, M. H., Abbound, P. C., et al. (1999). Why don’t physicians follow practice guidelines: A framework for improvement. JAMA, 282, 1458–1465.PubMedCrossRef Cabana, M. D., Rand, C. S., Pow, N. R., Wu, A. W., Wilson, M. H., Abbound, P. C., et al. (1999). Why don’t physicians follow practice guidelines: A framework for improvement. JAMA, 282, 1458–1465.PubMedCrossRef
Zurück zum Zitat Duff, J., Walker, K., & Omari, A. (2011). Translating venous thromboembolism (VTE) prevention evidence into practice: A multidisciplinary evidence implementation project. Worldviews on Evidence-Based Nursing, 8, 30–39.PubMedCrossRef Duff, J., Walker, K., & Omari, A. (2011). Translating venous thromboembolism (VTE) prevention evidence into practice: A multidisciplinary evidence implementation project. Worldviews on Evidence-Based Nursing, 8, 30–39.PubMedCrossRef
Zurück zum Zitat Goff, D. C. (2007). Integrating general health care in private community psychiatry practice. Journal of Clinical Psychiatry, 68(Suppl 4), 49–54.PubMed Goff, D. C. (2007). Integrating general health care in private community psychiatry practice. Journal of Clinical Psychiatry, 68(Suppl 4), 49–54.PubMed
Zurück zum Zitat Goff, D. C., Sullivan, L. M., McEvoy, J. P., Meyer, J. M., Nasrallah, H. A., Daumit, G. L., et al. (2005). A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophrenia Research, 80(1), 45–53.PubMedCrossRef Goff, D. C., Sullivan, L. M., McEvoy, J. P., Meyer, J. M., Nasrallah, H. A., Daumit, G. L., et al. (2005). A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophrenia Research, 80(1), 45–53.PubMedCrossRef
Zurück zum Zitat Grol, R., Eccles, M., & Wensing, M. (2005). Improving patient care: The implementation of change in clinical practice. Edinburgh: Elsevier. Grol, R., Eccles, M., & Wensing, M. (2005). Improving patient care: The implementation of change in clinical practice. Edinburgh: Elsevier.
Zurück zum Zitat Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., et al. (2005). Diagnosis and management of the metabolic syndrome: An american heart association/national heart, lung, and blood institute scientific statement. Circulation, 112(17), 2735–2752.PubMedCrossRef Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., et al. (2005). Diagnosis and management of the metabolic syndrome: An american heart association/national heart, lung, and blood institute scientific statement. Circulation, 112(17), 2735–2752.PubMedCrossRef
Zurück zum Zitat Harris, E. C., & Barraclough, B. (1998). Excess mortality of mental disorder. The British Journal of Psychiatry, 173, 11–53.PubMedCrossRef Harris, E. C., & Barraclough, B. (1998). Excess mortality of mental disorder. The British Journal of Psychiatry, 173, 11–53.PubMedCrossRef
Zurück zum Zitat Haupt, D. W., Rosenblatt, L. C., Kim, E., Baker, R. A., Whitehead, R., & Newcomer, J. W. (2009). Prevalence and predictors of lipid and glucose monitoring in commercially insured patients treated with second-generation antipsychotic agents. American Journal of Psychiatry, 166, 345–353.PubMedCrossRef Haupt, D. W., Rosenblatt, L. C., Kim, E., Baker, R. A., Whitehead, R., & Newcomer, J. W. (2009). Prevalence and predictors of lipid and glucose monitoring in commercially insured patients treated with second-generation antipsychotic agents. American Journal of Psychiatry, 166, 345–353.PubMedCrossRef
Zurück zum Zitat Marder, S. R., Essock, S. M., Miller, A. L., Buchanan, R. W., Casey, D. E., Davis, J. M., et al. (2004). Physical health monitoring of patients with schizophrenia. American Journal of Psychiatry, 161(8), 1334–1349.PubMedCrossRef Marder, S. R., Essock, S. M., Miller, A. L., Buchanan, R. W., Casey, D. E., Davis, J. M., et al. (2004). Physical health monitoring of patients with schizophrenia. American Journal of Psychiatry, 161(8), 1334–1349.PubMedCrossRef
Zurück zum Zitat Moeller, K. E., Rigler, S. K., Mayorga, A., Nazir, N., & Shireman, T. I. (2011). Quality of monitoring for metabolic effects ssociated with second generation antipsychotics in patients with schizophrenia on public insurance. Schizophrenia Research, 126, 117–123.PubMedCrossRef Moeller, K. E., Rigler, S. K., Mayorga, A., Nazir, N., & Shireman, T. I. (2011). Quality of monitoring for metabolic effects ssociated with second generation antipsychotics in patients with schizophrenia on public insurance. Schizophrenia Research, 126, 117–123.PubMedCrossRef
Zurück zum Zitat Morrato, E. H., Newcomer, J. W., Kamat, S., Baser, O., Harnett, J., & Cuffel, B. (2009). Metabolic screening after the american diabetes association’s consensus statement on antipsychotic drugs and diabetes. Diabetes Care, 32, 1037–1042.PubMedCrossRef Morrato, E. H., Newcomer, J. W., Kamat, S., Baser, O., Harnett, J., & Cuffel, B. (2009). Metabolic screening after the american diabetes association’s consensus statement on antipsychotic drugs and diabetes. Diabetes Care, 32, 1037–1042.PubMedCrossRef
Zurück zum Zitat Nasrallah, H. A., Meyer, J. M., Goff, D. C., McEvoy, J. P., Davis, S. M., Stroup, T. S., et al. (2006). Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline. Schizophrenia Research, 86, 15–22.PubMedCrossRef Nasrallah, H. A., Meyer, J. M., Goff, D. C., McEvoy, J. P., Davis, S. M., Stroup, T. S., et al. (2006). Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline. Schizophrenia Research, 86, 15–22.PubMedCrossRef
Zurück zum Zitat Newcomer, J. W. (2007a). Antipsychotic medications: Metabolic and cardiovascular risk. Journal of Clinical Psychiatry, 68(Suppl 4), 8–13.PubMed Newcomer, J. W. (2007a). Antipsychotic medications: Metabolic and cardiovascular risk. Journal of Clinical Psychiatry, 68(Suppl 4), 8–13.PubMed
Zurück zum Zitat Newcomer, J. W. (2007b). Metabolic considerations in the use of antipsychotic medications: A review of recent evidence. Journal of Clinical Psychiatry, 68(suppl 1), 20–27.PubMed Newcomer, J. W. (2007b). Metabolic considerations in the use of antipsychotic medications: A review of recent evidence. Journal of Clinical Psychiatry, 68(suppl 1), 20–27.PubMed
Zurück zum Zitat Roberts, L., Roalfe, A., Wilson, S., & Lester, H. (2007). Physical health care of patients with schizophrenia in primary care: A comparative study. Family Practice, 24, 34–40.PubMedCrossRef Roberts, L., Roalfe, A., Wilson, S., & Lester, H. (2007). Physical health care of patients with schizophrenia in primary care: A comparative study. Family Practice, 24, 34–40.PubMedCrossRef
Zurück zum Zitat Tooher, R., Middleton, P., Pham, C., Fitridge, R., Rowe, S., Babidge, W., et al. (2005). A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals. Annals of Surgery, 241, 397–415.PubMedCrossRef Tooher, R., Middleton, P., Pham, C., Fitridge, R., Rowe, S., Babidge, W., et al. (2005). A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals. Annals of Surgery, 241, 397–415.PubMedCrossRef
Metadaten
Titel
A Case Control Study of the Implementation of Change Model Versus Passive Dissemination of Practice Guidelines for Compliance in Monitoring for Metabolic Syndrome
verfasst von
Dawn I. Velligan
Desiree Castillo
Linda Lopez
Bren Manaugh
Charlotte Davis
Juanita Rodriguez
A. Camis Milam
Albana Dassori
Alexander L. Miller
Publikationsdatum
01.04.2013
Verlag
Springer US
Erschienen in
Community Mental Health Journal / Ausgabe 2/2013
Print ISSN: 0010-3853
Elektronische ISSN: 1573-2789
DOI
https://doi.org/10.1007/s10597-011-9472-z

Weitere Artikel der Ausgabe 2/2013

Community Mental Health Journal 2/2013 Zur Ausgabe

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.